Medical Devices
-
More than $7 Billion in Venture Financings for Medical Device Companies
Between 2018-2022, Wilson Sonsini represented 202 companies in 298 venture financing deals, totaling $7.02 billion in capital invested.
-
More than $5 Billion in M&A Deals Involving Medical Device Clients
Between 2018-2022, Wilson Sonsini represented medical device clients in 38 M&A transactions, totaling $5.35 billion in capital invested.
-
A Nationally Recognized and Ranked Life Sciences Practice
Wilson Sonsini has been named one of Law360's "Life Sciences Groups of the Year" and was also ranked No. 1 in the Life Sciences Law Firm Index published by Lake Whillans, based on research conducted by Breaking Media.
One of the driving forces behind the life sciences practice at Wilson Sonsini Goodrich & Rosati is its representation of medical device manufacturers and successful medical device entrepreneurs and investors. Wilson Sonsini's experience in the sector dates back to the industry's formative years, when exciting new companies first began to invent, develop, and commercialize breakthrough medical technologies.
A substantial number of the practitioners in the firm's medical device practice—including attorneys, patent agents, and scientific advisors—have advanced degrees in biology, chemistry, engineering, or other scientific fields. Similarly, a large number of our professionals have experience working in laboratory, medical, or research facilities. The team also includes attorneys who have served as in-house legal counsel for major life sciences companies.
Wilson Sonsini has consistently represented medical technology companies at all stages, from formation to exit. Our work with emerging medical device companies is typically focused on areas that are vital to early-stage enterprises, particularly intellectual property and finance. Those and other services we commonly provide are explained in the above tabs.
One of the driving forces behind the life sciences practice at Wilson Sonsini Goodrich & Rosati is its representation of medical device manufacturers and successful medical device entrepreneurs and investors. Wilson Sonsini's experience in the sector dates back to the industry's formative years, when exciting new companies first began to invent, develop, and commercialize breakthrough medical technologies.
A substantial number of the practitioners in the firm's medical device practice—including attorneys, patent agents, and scientific advisors—have advanced degrees in biology, chemistry, engineering, or other scientific fields. Similarly, a large number of our professionals have experience working in laboratory, medical, or research facilities. The team also includes attorneys who have served as in-house legal counsel for major life sciences companies.
Wilson Sonsini has consistently represented medical technology companies at all stages, from formation to exit. Our work with emerging medical device companies is typically focused on areas that are vital to early-stage enterprises, particularly intellectual property and finance. Those and other services we commonly provide are explained in the above tabs.
With Caption AI applications, ultrasound examinations can be easier and faster, enabling a broader set of healthcare professionals to conduct basic echocardiogram exams. This technology can help detect signs of diseases like heart failure in at-risk patients across doctors’ offices, the home, and alternate sites of care, potentially preventing hospitalizations and supporting improved clinical outcomes.
With Caption AI applications, ultrasound examinations can be easier and faster, enabling a broader set of healthcare professionals to conduct basic echocardiogram exams. This technology can help detect signs of diseases like heart failure in at-risk patients across doctors’ offices, the home, and alternate sites of care, potentially preventing hospitalizations and supporting improved clinical outcomes.
Miranda advises life sciences clients in partnering and licensing arrangements, M&A, and other transactions.
Miranda advises life sciences clients in partnering and licensing arrangements, M&A, and other transactions.
Wilson Sonsini offers medical device clients the benefit of working with the highly skilled intellectual property professionals in our patent and innovations counseling practice. In addition to advising on strategic matters, this team handles a significant number of patent filings. For example, in 2022, Wilson Sonsini had more than 850 U.S. and 2100 foreign patents issued on behalf of clients.
Wilson Sonsini offers medical device clients the benefit of working with the highly skilled intellectual property professionals in our patent and innovations counseling practice. In addition to advising on strategic matters, this team handles a significant number of patent filings. For example, in 2022, Wilson Sonsini had more than 850 U.S. and 2100 foreign patents issued on behalf of clients.
Wilson Sonsini consistently represents more companies that receive venture financing than any other U.S. law firm and consistently rank No. 1 for the number of company-side venture capital deals handled each year. In fact, Refinitiv ranked Wilson Sonsini as the top law firm by number of venture capital rounds raised in 2022 in its “Full Year 2022 Global Private Equity Legal Review.”
One reason for the firm's unmatched standing in the venture finance space is the long-standing relationships we have built working alongside innovative entrepreneurs to launch successful medical device companies. Another key driver of our success is our experience working with influential sources of funding: Wilson Sonsini represents more than 100 venture capital and private equity firms.
Wilson Sonsini consistently represents more companies that receive venture financing than any other U.S. law firm and consistently rank No. 1 for the number of company-side venture capital deals handled each year. In fact, Refinitiv ranked Wilson Sonsini as the top law firm by number of venture capital rounds raised in 2022 in its “Full Year 2022 Global Private Equity Legal Review.”
One reason for the firm's unmatched standing in the venture finance space is the long-standing relationships we have built working alongside innovative entrepreneurs to launch successful medical device companies. Another key driver of our success is our experience working with influential sources of funding: Wilson Sonsini represents more than 100 venture capital and private equity firms.
Wilson Sonsini has extensive experience advising maturing medical device companies as they reach important developmental milestones. Dating back to some of the most significant, landmark collaborations and partnering deals between industry pioneers, Wilson Sonsini's attorneys have helped medical technology clients structure and execute all manner of sophisticated, strategic transactions, working closely with each client to leverage their valuable intellectual property assets to achieve diverse market objectives.
The firm has advised life sciences companies on the structure of hundreds of corporate collaborations. Our experience includes developing, negotiating, and implementing:
- Co-branding and promotional agreements
- Cross-border agreements
- Research and development agreements
- Strategic alliances
- Joint development agreements
- Co-investment agreements
- Joint marketing agreements
In addition, our team has vast experience with a broad range of joint venture transactions involving medical device clients. We have also recently introduced clients to novel, creative agreements—such as build-to-buy agreements—aimed at benefiting multiple parties.
Wilson Sonsini has extensive experience advising maturing medical device companies as they reach important developmental milestones. Dating back to some of the most significant, landmark collaborations and partnering deals between industry pioneers, Wilson Sonsini's attorneys have helped medical technology clients structure and execute all manner of sophisticated, strategic transactions, working closely with each client to leverage their valuable intellectual property assets to achieve diverse market objectives.
The firm has advised life sciences companies on the structure of hundreds of corporate collaborations. Our experience includes developing, negotiating, and implementing:
- Co-branding and promotional agreements
- Cross-border agreements
- Research and development agreements
- Strategic alliances
- Joint development agreements
- Co-investment agreements
- Joint marketing agreements
In addition, our team has vast experience with a broad range of joint venture transactions involving medical device clients. We have also recently introduced clients to novel, creative agreements—such as build-to-buy agreements—aimed at benefiting multiple parties.
Regulatory approvals are critically important to growing medical device companies. Wilson Sonsini has a dedicated regulatory team that helps place medical device clients in a favorable position to clear regulatory hurdles and secure timely approvals. Our team also helps such clients remain in compliance with strictly enforced regulatory laws in the U.S. and international markets.
Regulatory approvals are critically important to growing medical device companies. Wilson Sonsini has a dedicated regulatory team that helps place medical device clients in a favorable position to clear regulatory hurdles and secure timely approvals. Our team also helps such clients remain in compliance with strictly enforced regulatory laws in the U.S. and international markets.
Many of Wilson Sonsini's successful medical device clients have opted to enter the capital markets, most often through an initial public offering. We are consistently ranked by Bloomberg, Thomson Reuters, and CapitalIQ as a leading advisor to companies and underwriters based on the number of completed IPOs and equity and equity-linked offerings. Over the past 20 years, the firm has represented some of the world’s most iconic companies, including Google, LinkedIn, and Lyft.
In a recent five-year span, Wilson Sonsini assisted life sciences clients in more than 30 public offering transactions that have raised nearly $3 billion. For example, the firm completed IPOs on behalf of medical devices clients ScienTech Medical, Ra Medical, and Establishment Labs. We've also represented medical device and equipment companies in several follow-on public offerings.
Many of Wilson Sonsini's successful medical device clients have opted to enter the capital markets, most often through an initial public offering. We are consistently ranked by Bloomberg, Thomson Reuters, and CapitalIQ as a leading advisor to companies and underwriters based on the number of completed IPOs and equity and equity-linked offerings. Over the past 20 years, the firm has represented some of the world’s most iconic companies, including Google, LinkedIn, and Lyft.
In a recent five-year span, Wilson Sonsini assisted life sciences clients in more than 30 public offering transactions that have raised nearly $3 billion. For example, the firm completed IPOs on behalf of medical devices clients ScienTech Medical, Ra Medical, and Establishment Labs. We've also represented medical device and equipment companies in several follow-on public offerings.
An acquisition can often be an ideal exit strategy for a medical device company, because it can signal the continued viability of a developing product line, as well as broader, even global distribution options that may not have otherwise been available to the company. Wilson Sonsini has represented a number of medical device and equipment clients that reached a point in their development where either selling part or all of the company proved to be the best strategic option.
Wilson Sonsini was ranked among the top firms worldwide, based on the number of M&A deals, in the 2022 Global M&A Review published by Refinitiv. While Wilson Sonsini has represented medical device clients in hundreds of smaller M&A transactions and limited intellectual property asset acquisitions, the firm has also been involved in some of the largest M&A deals in the life sciences industry. For example, Wilson Sonsini represented Pharmacyclics in its sale to AbbVie for approximately $21 billion.
An acquisition can often be an ideal exit strategy for a medical device company, because it can signal the continued viability of a developing product line, as well as broader, even global distribution options that may not have otherwise been available to the company. Wilson Sonsini has represented a number of medical device and equipment clients that reached a point in their development where either selling part or all of the company proved to be the best strategic option.
Wilson Sonsini was ranked among the top firms worldwide, based on the number of M&A deals, in the 2022 Global M&A Review published by Refinitiv. While Wilson Sonsini has represented medical device clients in hundreds of smaller M&A transactions and limited intellectual property asset acquisitions, the firm has also been involved in some of the largest M&A deals in the life sciences industry. For example, Wilson Sonsini represented Pharmacyclics in its sale to AbbVie for approximately $21 billion.
As medical device and equipment manufacturers grow, they often become involved in a proportionately larger number of business disputes. Our attorneys have successfully represented medical device companies engaged in litigation with competitors, suppliers, service providers, employees, and other entities, with disputes ranging from employment-related lawsuits to high-stakes patent litigation. We have also successfully defended medical device and equipment companies in class actions, including antitrust, consumer, and securities litigation matters. In addition to representing companies in federal and state courts throughout the U.S., our attorneys represent companies in arbitrations and mediations.
As medical device and equipment manufacturers grow, they often become involved in a proportionately larger number of business disputes. Our attorneys have successfully represented medical device companies engaged in litigation with competitors, suppliers, service providers, employees, and other entities, with disputes ranging from employment-related lawsuits to high-stakes patent litigation. We have also successfully defended medical device and equipment companies in class actions, including antitrust, consumer, and securities litigation matters. In addition to representing companies in federal and state courts throughout the U.S., our attorneys represent companies in arbitrations and mediations.